Tumor-Treating Fields Plus Temozolomide Versus Temozolomide Alone in Newly Diagnosed Glioblastoma: A Systematic Review and Bayesian Meta-Analysis with Meta-Regression.

Cancers (Basel) · 2026 · PMC13297347 · PMID 42352481

Europe PMC DOI

hedged sentence

0.3680

closest p · 7.4× alpha

0.3680

boldest claim

The sentences

did not reach statistical significancep = 0.368not close (p > 0.1)

18.6 months) that did not reach statistical significance ( p = 0.368), likely due to sample size limitations [ 31 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.